News Sentiment

SNN sentiment intelligence

Smith & Nephew SNATS Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 57 Balanced news tone 64 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 30.70 Week of 10 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

77/100 classification confidence.

Company focus 53

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+1.5% over one week, +0.4% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Smith & Nephew stock trades steadily as recent earnings highlight margin focus

Market Reaction

Balanced read

65/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 77/100 classification
One-week reaction 1.5% Price digesting
Trend fit Trend inactive 0.4% over four weeks
Fair value 9.1% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 24
Neutral 38
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 53
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
Market source 10
TradingView 8
ad-hoc-news.de 7
Stock Titan 6
GuruFocus 4
AD HOC NEWS 4
simplywall.st 4
Ad Hoc News 3

Event Lens

What the news is about

Classified themes
Market update 29
Earnings 18
Analyst action 5
Guidance 3
Capital return 3
Deals and strategy 3
Balance sheet 2
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 64
Ad Hoc News Direct company coverage

Smith & Nephew stock trades steadily as recent earnings highlight margin focus

Smith & Nephew's recent financial results indicate steady revenue growth but also highlight ongoing margin pressures, driven by cost inflation and R&D investments. The company, which specializes in orthopedics, sports medicine, and advanced wound care, reported approximately $5.5

Tone
Positive 63/100
Event
Earnings
Published
17 Jul 2026 09:40
Source
Ad Hoc News
The Manila Times Direct company coverage

Former Smith+Nephew Global Orthopaedics President Craig Gaffin Joins MedEdge Holdings as Partner

Craig Gaffin, former president of Smith+Nephew's global orthopaedics business, has joined MedEdge Holdings as a partner. MedEdge, founded in 2025, focuses on acquiring, building, and commercializing innovative surgical technology companies and expanding a nationwide commercial in

Tone
Neutral 50/100
Event
Market update
Published
16 Jul 2026 12:12
Source
The Manila Times
Medical Device Network Direct company coverage

Smith+Nephew unveils Lynx Coblation Laryngeal Wand for laryngology

Smith+Nephew has launched its Lynx Coblation Laryngeal Wand, a device designed for ENT surgeons performing laryngology procedures. The wand offers flexibility, an extended working length, and malleability, allowing for fine dissection and mass debulking at lower temperatures than

Tone
Positive 90/100
Event
Regulatory and legal
Published
16 Jul 2026 10:41
Source
Medical Device Network
Sahm Direct company coverage

Smith+Nephew introduces groundbreaking LYNX™ COBLATION™ Laryngeal Wand for ENT surgeons

Smith+Nephew has launched its new LYNX™ COBLATION™ Laryngeal Wand, a multi-purpose surgical tool designed specifically for ENT surgeons. This wand offers improved efficiency, better access to target anatomy, and a malleable shaft, leveraging Smith+Nephew’s COBLATION Technology fo

Tone
Positive 71/100
Event
Analyst action
Published
16 Jul 2026 10:12
Source
Sahm
Ad Hoc News Direct company coverage

Smith & Nephew stock holds steady as medical technology portfolio supports long-term growth

Smith & Nephew (GB0009223206) is a global medical technology company focusing on orthopedics, sports medicine, and advanced wound management. Its diversified portfolio, including established implant franchises and minimally invasive technologies, supports long-term growth and sta

Tone
Positive 76/100
Event
Market update
Published
16 Jul 2026 03:11
Source
Ad Hoc News
DirectorsTalk Interviews Direct company coverage

Smith & Nephew SNATS, Inc. (SNN): Investor Outlook on a Healthcare Giant with 10.98% Upside Potential

Smith & Nephew SNATS, Inc. (NYSE: SNN) is presented as a compelling investment opportunity in the healthcare sector, offering a 10.98% upside potential based on analyst targets. The company, known for orthopaedics, sports medicine, and advanced wound management, shows robust reve

Tone
Positive 72/100
Event
Guidance
Published
16 Jul 2026 02:12
Source
DirectorsTalk Interviews
TradingView Direct company coverage

SNN5772775 Bond Risk Profile

This page provides a risk profile for the Smith & Nephew plc 5.15% 20-MAR-2027 bond (SNN5772775). It offers an overview of the bond's coupon, redemption, and risks, along with a credit risk assessment highlighting security level, inflation protection, and issuer rating. Additiona

Tone
Neutral 50/100
Event
Analyst action
Published
15 Jul 2026 21:11
Source
TradingView
Finviz Direct company coverage

Smith+Nephew introduces groundbreaking LYNX COBLATION Laryngeal Wand for ENT surgeons

Smith+Nephew has launched its new LYNX COBLATION Laryngeal Wand, a multi-purpose surgical solution designed for ENT surgeons, specifically laryngologists. This device offers improved efficiency with self-clearing clog capabilities, better access to anatomy due to its long working

Tone
Positive 73/100
Event
Market update
Published
15 Jul 2026 11:11
Source
Finviz
TradingView Direct company coverage

WR33 Bond Coupon Profile — Rate & Payments

This article provides a coupon profile for the Smith & Nephew plc 4.25% 03-JUN-2038 bond (WR33) traded on the London Stock Exchange. It details the bond's current coupon rate of 4.25% and indicates that the next interest payment is scheduled for June 3, 2027. The article also men

Tone
Neutral 50/100
Event
Market update
Published
15 Jul 2026 03:15
Source
TradingView
TradingView Direct company coverage

XS338482183 Bond Profile — Key Metrics

This article provides a bond profile for the Smith & Nephew plc 4.25% 03-JUN-2038 bond, identified by XS338482183. It outlines key metrics such as issue and maturity dates, outstanding amount, face value, and coupon rate. The profile also includes a brief business description of

Tone
Neutral 50/100
Event
Market update
Published
14 Jul 2026 08:42
Source
TradingView
TradingView Direct company coverage

XS253247355 Bond Risk Profile

This page provides a risk profile for the Smith & Nephew plc 4.565% 11-OCT-2029 bond (XS253247355), listed on the Dusseldorf Stock Exchange. It offers an overview of the bond's coupon, redemption, and risks, including key metrics for credit risk assessment. The platform also sugg

Tone
Neutral 50/100
Event
Balance sheet
Published
14 Jul 2026 01:42
Source
TradingView
TradingView Direct company coverage

US83192PAA6 Bond Risk Profile

This page provides a risk profile for the US83192PAA6 corporate bond issued by Smith & Nephew plc, specifically its 2.032% bond maturing on 14-OCT-2030, traded on the Frankfurt Stock Exchange. It highlights key metrics for credit risk assessment, including security level and issu

Tone
Neutral 50/100
Event
Balance sheet
Published
13 Jul 2026 11:40
Source
TradingView
Ad Hoc News Direct company coverage

Smith & Nephew stock holds steady as investors await a catalyst

Smith & Nephew's stock remains focused on its orthopaedics, sports medicine, and advanced wound care franchises and is traded on the London Stock Exchange. Investors are looking to the company's trading updates and investor materials for future insights, as the stock's performanc

Tone
Neutral 50/100
Event
Market update
Published
13 Jul 2026 10:12
Source
Ad Hoc News
ad-hoc-news.de Direct company coverage

SNN stock holds steady as Smith & Nephew keeps its investor focus

Smith & Nephew plc, trading as SNN, maintains its focus on medical devices, specifically in orthopaedics, sports medicine, and wound care. The company's American depositary shares provide U.S. investors direct access to follow the London-listed medtech group, whose business model

Tone
Positive 60/100
Event
Market update
Published
10 Jul 2026 15:10
Source
ad-hoc-news.de
ad-hoc-news.de Direct company coverage

Smith & Nephew stock holds steady as the company expands evidence-led orthopedics

Smith & Nephew's stock performance is closely tied to its orthopedics and sports medicine segments, driven by procedure volumes. The company's business model focuses on selling implants and instruments for surgical settings, making operational execution and margin improvement cri

Tone
Neutral 50/100
Event
Earnings
Published
10 Jul 2026 14:10
Source
ad-hoc-news.de
AD HOC NEWS Direct company coverage

Smith & Nephew plc focuses on medical technology growth. Orthopedic and wound care portfolio underpi

Smith & Nephew plc is strengthening its position as a global medical technology provider, with a core focus on orthopedics and advanced wound management. The company specializes in products for joint replacement, trauma, sports medicine, and wound care, catering to hospitals and

Tone
Positive 73/100
Event
Market update
Published
07 Jul 2026 08:32
Source
AD HOC NEWS
AD HOC NEWS Direct company coverage

Smith & Nephew plc ADR highlights its medical technology portfolio as investors weigh long-term grow

Smith & Nephew plc ADR provides investors with exposure to a diversified medical technology business focusing on orthopedics, sports medicine, and advanced wound management. The company's performance is driven by factors such as aging populations and increasing surgical volumes,

Tone
Positive 70/100
Event
Market update
Published
06 Jul 2026 19:59
Source
AD HOC NEWS
AD HOC NEWS Direct company coverage

Smith & Nephew plc highlights its surgical technology portfolio as a global medtech player

Smith & Nephew plc is a global medical technology company specializing in orthopedics, sports medicine, and advanced wound management. The company's diverse portfolio includes products for joint replacement, trauma treatment, and chronic wound care, catering to an international m

Tone
Positive 65/100
Event
Market update
Published
05 Jul 2026 09:09
Source
AD HOC NEWS
Ad-hoc-news.de Direct company coverage

Smith & Nephew focuses on medical devices as a long-term play

Smith & Nephew plc is positioning itself as a global medical technology group with a diversified portfolio spanning orthopedics, sports medicine, and advanced wound management, targeting long-term investment due to structural growth in healthcare and aging populations. The compan

Tone
Positive 72/100
Event
Market update
Published
03 Jul 2026 21:11
Source
Ad-hoc-news.de
Bez Kabli Direct company coverage

Smith & Nephew (LON:SN) buyback makes headlines as U.S. knees keep pressure on

Smith & Nephew's shares saw minimal movement despite a significant share buyback, with the company repurchasing 1.59 million shares between June 26 and July 2. The buyback is part of a larger $500 million plan, 64% of which has been utilized. Investors remain cautious due to slow

Tone
Neutral 50/100
Event
Capital return
Published
03 Jul 2026 19:11
Source
Bez Kabli
Stock Titan Direct company coverage

Smith & Nephew (SNN) reserves 150,000 shares for employee plans via block admission

Smith & Nephew plc has applied to the London Stock Exchange for the block admission of 150,000 ordinary shares, each with a par value of US20¢. These shares are intended to be used for the company's employee share plans and are expected to begin trading on July 6, 2026. Once issu

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 09:41
Source
Stock Titan
TradingView Direct company coverage

REG - Smith & Nephew Plc - Block Admission Application

Smith & Nephew plc has applied to the London Stock Exchange for the admission of 150,000 ordinary shares to trading, expected on July 6, 2026. These shares are reserved under a block admission to settle awards from the Company's employee share plans and will rank equally with exi

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 08:41
Source
TradingView
Stock Titan Direct company coverage

Smith & Nephew (SNN) details 845M voting shares and treasury holdings

Smith & Nephew plc has released an update on its share capital and voting rights as of June 30, 2026. The company reported a total issued share capital of 877,733,750 ordinary shares, including 32,697,503 shares held in treasury which do not carry voting rights. Consequently, the

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 11:10
Source
Stock Titan
TradingView Direct company coverage

Price to earnings forward of Smith & Nephew plc – BX:NPW1

This page from TradingView provides financial information for Smith & Nephew plc (BX:NPW1). It focuses on the company's price to earnings forward metric. The page appears to be a financial data snippet rather than a full article.

Tone
Neutral 50/100
Event
Earnings
Published
01 Jul 2026 06:09
Source
TradingView
GuruFocus Direct company coverage

Cevian Capital II GP LTD Increases Stake in Smith & Nephew PLC

Cevian Capital II GP LTD has significantly increased its stake in Smith & Nephew PLC by acquiring an additional 9,757,713 shares, bringing its total ownership to 110,804,501 shares, representing 13.09% of Cevian Capital's portfolio. The transaction, executed at $29.39 per share,

Tone
Positive 73/100
Event
Deals and strategy
Published
01 Jul 2026 02:09
Source
GuruFocus